Dosing in Moderately to Severely Active UC - TREMFYA
View dosing information for TREMFYA® (guselkumab) in the treatment of adults with moderately to severely active UC. See full Prescribing & Safety Information.
Moderately to Severely Active UC Dosing | TREMFYA® (guselkumab) …
Learn about TREMFYA® (guselkumab) dosing options for adults with moderately to severely active ulcerative colitis (UC). See full Prescribing & Safety Information.
TREMFYA – Dose Escalation During TREMFYA Maintenance Therapy …
Jun 4, 2025 · A summary of clinical data regarding TREMFYA® (guselkumab) dose escalation during maintenance therapy in ulcerative colitis.
Moderately to Severely Active UC | TREMFYA® (guselkumab)
Learn about TREMFYA® (guselkumab) for adults with moderately to severely active ulcerative colitis (UC). See full Prescribing & Safety Information.
Preparation and Administration of TREMFYA for Adult Patients
Sep 13, 2025 · In adult patients with moderately to severely active ulcerative colitis (UC), the recommended induction dosage of TREMFYA is 200 mg administered by intravenous infusion over …
Moderately to Severely Active UC Resources - TREMFYA
Discover UC information for TREMFYA ®, including details about results, dosing, safety, and personalized support. Use the IFU to guide you on how to properly inject with TREMFYA ®. Watch a …
Dosage Forms and Strengths: TREMFYA® is available as 100 mg/mL and 200 mg/2 mL for subcutaneous injection and as a 200 mg/20 mL (10 mg/mL) single dose vial for intravenous infusion.
TREMFYA® in Moderately to Severely Active UC | TREMFYA® …
Dosage Forms and Strengths: TREMFYA ® is available as 100 mg/mL and 200 mg/2 mL for subcutaneous injection and as a 200 mg/20 mL (10 mg/mL) single dose vial for intravenous infusion.
TREMFYA® (guselkumab) achieves U.S. approval for subcutaneous …
Sep 19, 2025 · “With today’s approval, TREMFYA is the first and only IL-23 inhibitor to offer inflammatory bowel disease patients robust clinical and endoscopic results with a fully subcutaneous …
Managing Ulcerative Colitis With Tremfya - WebMD
Tremfya is given once every four weeks for the first three doses as an infusion into a vein, and then once every four or eight weeks thereafter as an injection under the skin.